Meta Biomed Co. Ltd. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
2,171
4,774
970
749
4,081
Depreciation, Depletion & Amortization
3,228
3,410
3,638
3,717
3,324
Other Funds
-
-
345
32
-
Funds from Operations
6,008
1,940
9,711
3,883
4,144
Changes in Working Capital
2,296
2,236
4,777
1,150
4,393
Net Operating Cash Flow
3,712
296
4,933
5,033
249
Capital Expenditures
6,758
7,257
7,793
6,127
11,065
Sale of Fixed Assets & Businesses
109
598
5,923
779
672
Purchase/Sale of Investments
8,746
2,994
2,462
1,616
4,344
Net Investing Cash Flow
14,894
3,100
1,497
6,184
5,158
Cash Dividends Paid - Total
254
254
188
214
215
Issuance/Reduction of Debt, Net
1,370
1,629
10,618
3,211
7,843
Net Financing Cash Flow
11,915
1,375
5,251
3,141
7,467
Net Change in Cash
744
2,015
904
2,100
1,950
Free Cash Flow
888
4,459
378
862
9,045
Other Sources
560
631
967
895
951
Change in Capital Stock
10,799
-
5,900
175
160
Exchange Rate Effect
11
7
275
110
111
Other Uses
59
66
62
115
60

About Meta Biomed Co.

View Profile
Address
Osong Life Science Complex
Cheongju NC 28161
Korea, Republic Of
Employees -
Website http://www.meta-biomed.com
Updated 09/14/2018
Meta Biomed Co., Ltd. engages in the manufacture and sale of surgical and other medical devices. It operates through the following business divisions: Dental, Suture Materials and Bone Material. The Dental division produces endodontic products, temporary materials, resin products and bone graft substitute.